Download pdf
Current status and trend analysis of chronic heart failure research based on CNKI database and CiteSpace
- 1 Lhasa People’s Hospital
- 2 Lhasa People’s Hospital
* Author to whom correspondence should be addressed.
Abstract
Purpose: Chronic heart failure (CHF) is a serious cardiac disease and has become a common and high-incidence disease worldwide. This study aims to investigate the current status and trends of research on CHF over the past decade (2013-2023), in order to understand the latest developments in this field and future research directions. Methods: Using the China National Knowledge Infrastructure (CNKI) as the data source, visual analysis software CiteSpace 5.5 R1 was employed to visualize and analyze CHF-related research, exploring authors, institutions, keywords, and development trends of relevant studies. Results: A total of 1907 articles were included. Visual analysis revealed that research authors were relatively dispersed, with few collaborative publications. The collaboration among main research teams was insufficient, and the main research institutions were also relatively dispersed. Hot keywords included chronic heart failure, heart failure, chronic congestive heart failure, cardiac function, quality of life, prognosis, ventricular remodeling, brain natriuretic peptide, etc., forming nine clusters. Conclusion: The publication volume of CHF over the past decade showed a trend of gradual decrease followed by an increase. The impact of cardiac function on patients’ prognosis and quality of life has received relatively high attention in the field of chronic heart failure.
Keywords
Chronic heart failure, current status, trend analysis, CNKI database, CiteSpace
[1]. Zhang, Y. N., Siri, G. L., Yang, H. X., et al. (2023). Interpretation of the European Society of Cardiology Heart Failure Association “Clinical Consensus Statement: Definition, Epidemiology, Management, and Prevention of Worsening Chronic Heart Failure” [J]. World Clinical Drugs, 44(10), 1017-1021.
[2]. Du, Q. (2017, February 21). Preliminary Discussion on the Physiological Mechanism of Anti-Angiotensin II Type 1 Receptor Autoantibodies in Chronic Heart Failure. Cardiovascular Hospital, Xiamen University, Fujian Province.
[3]. Wang, N. F. (2017). Complications of Chronic Heart Failure and Their Impact on Prognosis [J]. Electronic Journal of Clinical Medicine Literature, 4(42), 8179+8182.
[4]. Yancy, C. W., Jessup, M., Bozkurt, B., et al. (2017). 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure [J]. Journal of the American College of Cardiology, 70(6), 776-803.
[5]. Ziaeian, B., & Fonarow, G. C. (2016). Epidemiology and aetiology of heart failure. Nat Rev Cardiol, 13(6), 368-78.
[6]. Triposkiadis, F., Xanthopoulos, A., Parissis, J., Butler, J., & Farmakis, D. (2022). Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev, 27(1), 337-344.
[7]. Savarese, G., & Lund, L. H. (2017). Global public health burden of heart failure. Cardiac failure review, 3(1), 7.
[8]. Recchia, F. A., & Lionetti, V. (2007). Animal models of dilated cardiomyopathy for translational research. Veterinary research communications, 31(1), 35-41.
[9]. McMurray, J. J., Packer, M., Desai, A. S., et al. (2014). Angiotensin–neprilysin inhibition versus enalapril in heart failure. New England Journal of Medicine, 371(11), 993-1004.
[10]. Cleland, J. G., Daubert, J. C., Erdmann, E., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352(15), 1539-49.
[11]. McMurray, J. J., Packer, M., Desai, A. S., et al. (2014). Angiotensin–neprilysin inhibition versus enalapril in heart failure. New England Journal of Medicine, 371(11), 993-1004.
[12]. Luo, J. H., & He, X. H. (2013). Research Progress of Stem Cell Therapy for Heart Diseases [J]. Medical Review, 19(03), 410-414.
Cite this article
Quzhen,B.;Shi,X. (2024). Current status and trend analysis of chronic heart failure research based on CNKI database and CiteSpace. Theoretical and Natural Science,49,30-38.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).